Loading clinical trials...
Loading clinical trials...
A Multi-Center, Double-Masked, Vehicle-Controlled, Evaluation of the Safety of CSF-1 in Presbyopic Subjects
Conditions
Interventions
CSF-1
Vehicle
Locations
12
United States
Orasis Investigative Site
Newport Beach, California, United States
Orasis Investigative Site
Petaluma, California, United States
Orasis Investigative Site
Colorado Springs, Colorado, United States
Orasis Investigative Site
Danbury, Connecticut, United States
Orasis Investigative Site
Rock Island, Illinois, United States
Orasis Investigative Site
Overland Park, Kansas, United States
Start Date
April 22, 2022
Primary Completion Date
December 1, 2022
Completion Date
December 1, 2022
Last Updated
June 11, 2025
NCT06060041
NCT03135327
NCT07051720
NCT06948357
NCT06869044
NCT04465409
Lead Sponsor
Orasis Pharmaceuticals Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions